NASDAQ: TIL

Instil Bio, Inc.

Healthcare | Biotechnology

No licensed closing price on file for TIL. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

Instil Bio, Inc. (NASDAQ: TIL) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 07:45 UTC.

What Instil Bio, Inc. does

The company is a biotechnology firm focused on identifying and developing innovative therapeutic opportunities. Recently, its wholly owned subsidiary Axion Bio discontinued development of AXN-2510, a bispecific antibody for solid tumor cancers that had been in-licensed from ImmuneOnco, with the collaboration agreement terminated. Prior to this program, the company pursued development of cell therapies, including a proprietary folate receptor alpha co-stimulatory antigen receptor tumor infiltrating lymphocyte cell therapy for cancer treatment.

Summarized from Instil Bio, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation	8-K 2026-06-11
Return on equity	95.30%

Charts

Charts are in the appInteractive charts for TIL are available in Oxford Ledge.
Open TIL in Oxford Ledge →

SEC Filings

SEC EDGAR ↗

Recent Insider Activity

Source: SEC EDGAR · Filed 2026-06-12

Most recent filed transactions — June 2026:

2026-06-12DirectorStock Option (Right to Buy)Award6,500—
2026-06-12DirectorStock Option (Right to Buy)Award6,500—
2026-06-12DirectorStock Option (Right to Buy)Award0—

Top Institutional Holders (latest 13F)

Source: SEC EDGAR · As of 2026-Q2

Curative Ventures V LLC1,899,004$14.60M0.0%
BML Capital Management, LLC645,600$4.96M0.0%
CPMG Inc410,922$3.39M0.0%

View QoQ ownership changes →Full institutional ownership →

Recent 8-K Events (parsed from SEC filings)All events →

Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

2026-04-03AuditorChanges in registrant's certifying accountantRSM US LLPEstimatedSEC 8-K →
2024-02-14Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2023-02-27Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →

Company news

View all →

No qualifying company news in the archive. Full tape in the platform →

Questions this page answers

What does Instil Bio, Inc. do?

The company is a biotechnology firm focused on identifying and developing innovative therapeutic opportunities.

When did TIL last file with the SEC?

Instil Bio, Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-11. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 07:45 UTC. This page is also available as JSON at /api/data?ticker=TIL and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for TIL and 5,000+ tickers.

Create a free account — keep TIL

For your agent

GET /api/data?ticker=TIL

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt